Document/ExhibitDescriptionPagesSize
1: 10-Q Quarterly Report HTML 1.61M
2: EX-31.1 Certification -- §302 - SOA'02 HTML 24K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 22K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 22K
11: R1 Cover Page HTML 75K
12: R2 Condensed Consolidated Balance Sheets HTML 122K
13: R3 Condensed Consolidated Balance Sheets HTML 41K
(Parenthetical)
14: R4 Condensed Consolidated Statements of Operations HTML 106K
and Comprehensive Loss
15: R5 Condensed Consolidated Statements of Stockholders' HTML 88K
Equity
16: R6 Condensed Consolidated Statements of Cash Flows HTML 100K
17: R7 Organization HTML 26K
18: R8 Basis of Presentation and Summary of Significant HTML 46K
Accounting Policies and Estimates
19: R9 Accumulated Other Comprehensive Income (Loss) HTML 29K
20: R10 Fair Value Measurements HTML 46K
21: R11 Inventories HTML 29K
22: R12 Revenue HTML 92K
23: R13 Accrued Liabilities HTML 41K
24: R14 Notes Payable, net HTML 35K
25: R15 Lease Obligations HTML 33K
26: R16 Capitalization and Equity Structure HTML 116K
27: R17 Stock-based Compensation HTML 62K
28: R18 Income Taxes HTML 25K
29: R19 Commitments and Contingencies HTML 30K
30: R20 Net (Loss) Income Per Share HTML 59K
31: R21 Segment Disclosures HTML 90K
32: R22 Basis of Presentation and Summary of Significant HTML 66K
Accounting Policies and Estimates (Policies)
33: R23 Accumulated Other Comprehensive Income (Loss) HTML 28K
(Tables)
34: R24 Fair Value Measurements (Tables) HTML 44K
35: R25 Inventories (Tables) HTML 30K
36: R26 Revenue (Tables) HTML 71K
37: R27 Accrued Liabilities (Tables) HTML 42K
38: R28 Notes Payable, net (Tables) HTML 29K
39: R29 Lease Obligations (Tables) HTML 29K
40: R30 Capitalization and Equity Structure (Tables) HTML 89K
41: R31 Stock-based Compensation (Tables) HTML 60K
42: R32 Net (Loss) Income Per Share (Tables) HTML 61K
43: R33 Segment Disclosures (Tables) HTML 88K
44: R34 Organization (Details) HTML 33K
45: R35 Basis of Presentation and Summary of Significant HTML 33K
Accounting Policies and Estimates (Details)
46: R36 Accumulated Other Comprehensive Income (Loss) HTML 31K
(Details)
47: R37 Fair Value Measurements - Fair Value Hierarchies HTML 32K
(Details)
48: R38 Fair Value Measurements - Change in Level 3 HTML 28K
(Details)
49: R39 Inventories (Details) HTML 29K
50: R40 Revenue - Deferred Revenue (Details) HTML 33K
51: R41 Revenue - Deferred Revenue Activity (Details) HTML 27K
52: R42 Revenue - Additional Information (Details) HTML 58K
53: R43 Revenue - Disaggregation of Revenue (Details) HTML 59K
54: R44 Accrued Liabilities - Schedule of Accrued HTML 30K
Liabilities (Details)
55: R45 Accrued Liabilities - Product Maintenance and HTML 31K
Warranty (Details)
56: R46 Notes Payable, net - Additional Information HTML 52K
(Details)
57: R47 Notes Payable, net - Debt Repayment (Details) HTML 39K
58: R48 Lease Obligations -Additional Information HTML 33K
(Details)
59: R49 Lease Obligations-Schedule of lease maturity HTML 35K
(Details)
60: R50 Capitalization and Equity Structure - Additional HTML 130K
Information (Details)
61: R51 Capitalization and Equity Structure - Warrants HTML 64K
(Details)
62: R52 Capitalization and Equity Structure - Valuation HTML 75K
Assumptions (Details)
63: R53 Stock-based Compensation - Additional Information HTML 49K
(Details)
64: R54 Stock-based Compensation - Stock Option Activity HTML 64K
(Details)
65: R55 Stock-based Compensation - RSU Activity (Details) HTML 41K
66: R56 Stock-based Compensation - Compensation Expense HTML 31K
(Details)
67: R57 Commitments and Contingencies (Details) HTML 36K
68: R58 Net (Loss) Income Per Share - Earnings Per Share HTML 56K
(Details)
69: R59 Net (Loss) Income Per Share - Antidilutive Shares HTML 32K
(Details)
70: R60 Segment Disclosures - Operating Segments (Details) HTML 46K
71: R61 Segment Disclosures - Geographical Segments HTML 49K
(Details)
74: XML IDEA XML File -- Filing Summary XML 134K
72: XML XBRL Instance -- ekso-20220630_htm XML 2.02M
73: EXCEL IDEA Workbook of Financial Reports XLSX 138K
7: EX-101.CAL XBRL Calculations -- ekso-20220630_cal XML 138K
8: EX-101.DEF XBRL Definitions -- ekso-20220630_def XML 519K
9: EX-101.LAB XBRL Labels -- ekso-20220630_lab XML 1.42M
10: EX-101.PRE XBRL Presentations -- ekso-20220630_pre XML 837K
6: EX-101.SCH XBRL Schema -- ekso-20220630 XSD 147K
75: JSON XBRL Instance as JSON Data -- MetaLinks 360± 537K
76: ZIP XBRL Zipped Folder -- 0001549084-22-000051-xbrl Zip 355K
(1)I have reviewed this Quarterly Report on Form 10-Q of Ekso Bionics Holdings, Inc.;
(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period covered by this report;
(3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;
(4)The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company
and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the
company’s internal control over financial reporting; and
(5)The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the
company’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.
